Clinical trial
Combination Chemotherapy in Treating Patients With Metastatic Cancer of an…
NCT00022178 · The Christie NHS Foundation Trust, Other · Unknown status
Key facts
| NCT number | NCT00022178 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin |
| Official title | An Open Label Prospective Randomised Study Comparing The Use Of Vincristine, Adriamycin And Cyclophosphamide (VAC) Versus Epirubicin, Cisplatin And Continuous 5-Flourouracil (ECF) In Patients With Unknown Primary Carcinoma (UPC) |
| Lead sponsor | The Christie NHS Foundation Trust, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma of Unknown Primary |
| Intervention type | Drug |
| Interventions | cisplatin, cyclophosphamide, doxorubicin hydrochloride, epirubicin hydrochloride, fluorouracil, vincristine sulfate |
| Start date | Dec 1, 1998 |
| First posted | Feb 27, 2004 |
| Last update posted | Sep 20, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: